In the context of chronic bowel inflammation, alteration or loss of TGFβ-mediated immune regulation in combination with the effects of dysregulated TGFβ signaling in damaged epithelium and the resulting insufficient control of cell growth, can lead to tumor development [7]. Here, TGFB1 is linked to neoplasm.